Boutique pharma launches demand precision. This white paper reveals how early insights, targeted engagement, and agile teams drive stronger outcomes in smaller markets—download the white paper to explore the boutique launch blueprint.

Biopharma teams are under pressure to move candidates from discovery to IND faster. This white paper shows how smarter, centralized partnerships streamline R&D, cut costs, and scale innovation. Download for free to learn how to accelerate your pipeline.

Payer-sourced real-world data offers the completeness and reliability biopharma needs to strengthen R&D, improve regulatory readiness, and support market access strategies. Download now to see how integrated datasets and expert analytics drive better evidence generation.

Formulating oral medicines is getting harder as today’s molecules push the limits of solubility, stability, and bioavailability. This white paper shows how softgel technology overcomes those barriers to streamline development, improve adherence, and reduce risk. Download Now.

Discover how Fiber-seq enhances long-read sequencing with single-molecule chromatin insight to drive breakthroughs in gene regulation and disease research. Download this whitepaper to learn more.

A scientific approach to decision-making can improve clinical development, as well as corporate, portfolio, & product strategy. Here’s a framework.

Biopharma teams are under growing pressure to advance assets faster, navigate rising complexity and make earlier decisions with greater confidence. Download the infographic to explore the strategies that are reshaping early-stage development and driving stronger outcomes across the pipeline.

Detecting Low-Abundance Biomarkers in Blood and CSF: Challenges and Solutions

High-sensitivity biomarker platforms are revolutionizing clinical neuroscience, but significant challenges remain. The blood-brain barrier, complex matrices, and the ultra-low abundance of biomarkers such as mutant huntingtin and amyloid-beta often limit the precision of early disease detection and therapeutic monitoring.

In this vodcast, two biomarker experts delve into practical solutions using ultra-sensitive technologies and validated workflows that are advancing precision medicine in neuroscience.

Explore a faster, more efficient path to commercializing your companion diagnostic. This infographic shows how you can accelerate development, reduce delays, and reach the right patients sooner. Download this infographic to learn more.

Are you grappling with the complexities of process validation in cell and gene therapy development? Listen to experienced cell & gene CDMO experts as they offer insights on the process to ease your journey in this on-demand webinar. Unlock the secrets to seamless cell and gene therapy development!